Press release
Hyperpigmentation Treatment Market Growth to be Fuelled by Advancements in Technology
Hyperpigmentation refers to darkening of the skin characterized by excess production or accumulation of melanin, a pigment which primarily determines the skin color. Hyperpigmentation can be a diffuse (spread over large area of a body) or focal (restricted to certain body part) and can affect any part of the body, mostly face, hands and chest. Hyperpigmentation is clinically harmless condition but it can be of concern cosmetically. Some of the common causes of hyperpigmentation include inflammation, skin injury, phytophotodermatitis (photo toxicity), lentigines, melisma, melanoma or even it can be a drug-induced condition. Hyperpigmentation can be treated by two approaches viz. Drug/Pharmacological treatment and Cosmetic treatment.Expanding aging population and increasing incidence of skin disorders are the primary contributors to the growth of global hyperpigmentation treatment market. Moreover, growing demand for the skin lightening, upgraded lifestyle, global climate changes and global warming, rising number of smokers, increasing disposable income can drive the global hyperpigmentation treatment market. In spite of this stringent regulatory policies and safety concerns associated with the use of cosmetic products for skin lightening can hinder the growth of global hyperpigmentation treatment market.
Request for Table of Contents @ https://www.persistencemarketresearch.com/toc/9983
The global hyperpigmentation treatment market has been segmented on the basis of treatment type, retail sales channels and geography.
Based on treatment type, the global hyperpigmentation treatment market is divided into following:
Pharmacological therapy
Synthetic Origin
Hydroquinone
Topical Corticoids (steroids)
Azelaic acid
Ascorbic acid (Vitamin C)
Natural Origin
Kojik acid
Liquorice extract
Citrus Extracts
Non-pharmacological/Cosmetic Therapy
Laser treatment
Chemical peels and bleach
Microdermabrasion
Skin grafting/Plastic surgery
Based on retail sales channels, the global hyperpigmentation treatment market is divided into following:
Skin Clinics
Drug and Cosmetic Stores
Hypermarkets and Supermarkets
The global hyperpigmentation treatment market is expected to grow with a significant CAGR due to availability of various treatment options and rapid adoption of new technologies. The non-pharmacological or cosmetic therapy sub-segment is expected to contribute more to the global hyperpigmentation market owing to their quick results. Customer demand for the skin brightening products is expected to increase during the forecast period of 2016-2021 due to increasing aesthetic concern.
Geographically, the global hyperpigmentation treatment market is segmented into five key regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America will continue to hold the largest share in global hyperpigmentation treatment market because of rising aging demographics. Asia Pacific is expected to be the most lucrative region for the new entrants in the global hyperpigmentation treatment market.
Request a Sample Brochure of the Report @ https://www.persistencemarketresearch.com/samples/9983
Some of the major players in the global hyperpigmentation treatment market include Biocosmetic Research Labs, Episciences, Inc., Vivier Pharma, Inc., La Roche-Posay, Pierre Fabre Dermo Cosmetique, Bayer AG, Alvogen, Inc., Allergan, Inc., Obagi Medical Products Inc., SkinCeuticals International, L’oréal Paris and others.
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
Telephone - +1-646-568-7751
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hyperpigmentation Treatment Market Growth to be Fuelled by Advancements in Technology here
News-ID: 1065043 • Views: …
More Releases from Persistence Market Research
Vaginitis Treatment Drug Market Growth Accelerated by Rising Awareness of Women' …
The global vaginitis treatment drug market is experiencing consistent growth, reflecting the growing global emphasis on women's reproductive health and wellness. Valued at approximately US$3.3 billion in 2024, the market is expected to reach US$5.3 billion by 2031, registering a compound annual growth rate (CAGR) of 5.0% during the forecast period (2024-2031). This steady expansion is attributed to multiple factors including the rising prevalence of bacterial vaginosis (BV), yeast infections,…
Assembly Line Solutions Market Poised for 7.3% CAGR Growth Through 2032, Says Pe …
The global Assembly Line Solutions Market is witnessing a profound transformation, driven by the accelerating adoption of automation and smart manufacturing technologies across industrial sectors. The market, valued at US$294.5 billion in 2025, is projected to reach approximately US$483.5 billion by 2032, expanding at a robust CAGR of 7.3% over the forecast period (2025-2032). This growth reflects the rising demand for intelligent manufacturing systems that can enhance productivity, minimize downtime,…
Retinal Biologics Market to Reach New Heights with Rising AMD Cases, Says Persis …
The global retinal biologics market is witnessing dynamic transformation, driven by an aging population, rising prevalence of retinal diseases, and advances in biotechnology. Retinal biologics are therapeutic agents derived from living organisms that target the underlying molecular mechanisms responsible for retinal disorders. These biologics, such as Eylea (aflibercept), Lucentis (ranibizumab), and Vabysmo (faricimab-svoa), have revolutionized the management of conditions like age-related macular degeneration (AMD), diabetic retinopathy, and diabetic macular edema…
Neuroendocrine Carcinoma Treatment Market Growth Driven by Novel Therapies, Says …
Neuroendocrine carcinoma (NEC) is a rare and complex cancer that arises from neuroendocrine cells, which are spread across various organs in the body, including the gastrointestinal tract, pancreas, and lungs. As a result, the treatment landscape for NEC is multifaceted, involving a range of therapeutic modalities including surgery, chemotherapy, targeted therapy, immunotherapy, and radioligand therapy. The global market for neuroendocrine carcinoma treatment has seen significant growth over the past decade,…
More Releases for Hyperpigmentation
Surge In Pigmentation Disorders Spurs Growth In Hyperpigmentation Disorders Trea …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Hyperpigmentation Disorder Treatment Industry Market Size Be by 2025?
The market size for hyperpigmentation disorder treatment has seen significant growth in the past few years. The market, which was valued at $5.73 billion in 2024, is projected to reach $6.14 billion in 2025, representing a compound…
Hyperpigmentation Treatment Market to Witness an Outstanding Growth by 2030
The Hyperpigmentation Treatment Market 2024 Report makes available the current and future technical and financial analysis of the industry. It is one of the most comprehensive and important additions to the USD Analytics archive of market research studies. It offers detailed research and analysis of key aspects of the global Hyperpigmentation Treatment market. This global report explores the key factors affecting the growth of the dynamic Hyperpigmentation Treatment market, including…
Hyperpigmentation Market to Witness Growth by 2032, Estimates DelveInsight
DelveInsight's "Hyperpigmentation Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Hyperpigmentation, historical and forecasted epidemiology as well as the Hyperpigmentation market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Hyperpigmentation market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Hyperpigmentation market size from 2019 to 2032, segmented…
Hyperpigmentation Market to Witness Growth by 2032, Estimates DelveInsight
DelveInsight's "Hyperpigmentation Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Hyperpigmentation, historical and forecasted epidemiology as well as the Hyperpigmentation market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Hyperpigmentation market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Hyperpigmentation market size from 2019 to 2032,…
Hyperpigmentation Treatment Market Pegged to Expand Robustly During 2016-2022
Hyperpigmentation refers to darkening of the skin characterized by excess production or accumulation of melanin, a pigment which primarily determines the skin color. Hyperpigmentation can be a diffuse (spread over large area of a body) or focal (restricted to certain body part) and can affect any part of the body, mostly face, hands and chest. Hyperpigmentation is clinically harmless condition but it can be of concern cosmetically. Some of the…
Hyperpigmentation Treatment Devices Industry Outlook and Market Growth Till 2026
The Global Hyperpigmentation Treatment Devices Market, was valued at US$ 1150 Mn in 2017 and is projected to exhibit a CAGR of 7.2% over the forecast period (2018 – 2026), as highlighted in a new report published by Coherent Market Insights.
Hyperpigmentation is one of the most common skin problems across the globe. According to a study published in the journal Dermatology Therapy in September 2017, melasma, which is a…
